
ABEONA THERAPEUTICS INC.
Nasdaq · Pharmaceutical Preparations
Company Overview
A concise company profile alongside the latest public filing activity.
Abeona Therapeutics develops gene and cell therapies for severe genetic and rare diseases, including skin and eye disorders, using its proprietary AAV-based gene therapy delivery platforms.
Company profile sourced from SEC filings.
Corporate Insider Trades
Open-market purchases and sales by directors, officers, and other company insiders.
| Insider | Type | Value | Shares / Price | Date |
|---|---|---|---|---|
| Seshadri VishwasChief Executive Officer | Sell | $101K | 19,608at $5.16 | Sep 29, 2026 |
| Vazzano Joseph WalterChief Financial Officer | Sell | $47K | 9,191at $5.16 | Sep 29, 2026 |
| O'Malley Brendan M.SVP, Chief Legal Officer | Sell | $35K | 6,727at $5.16 | Sep 29, 2026 |
| Vasanthavada MadhavChief Commercial Officer | Sell | $25K | 4,902at $5.16 | Sep 29, 2026 |
Source: SEC EDGAR Form 4 filings
Congressional Trades
Recent disclosures by members of the U.S. House and Senate.
Source: Senate eFD and House Clerk STOCK Act disclosures
Get notable ABEO activity by email
Free alerts for the insider and congressional trades worth watching.
For informational purposes only, not investment advice. Filings can be delayed, corrected, or amended. Trading activity alone does not predict future performance.